Jingjing Li
Shenyang Pharmaceutical University(CN)University of North Carolina at Chapel Hill(US)Xuzhou Medical College(CN)Anhui Medical University(CN)Tianjin Medical University Cancer Institute and Hospital(CN)Zhengzhou University of Science and Technology(CN)Henan University of Engineering(CN)Yunnan Provincial Hospital of Traditional Chinese Medicine(CN)Nanjing Drum Tower Hospital(CN)Xuzhou Central Hospital(CN)Henan Forestry Vocational College(CN)Second Hospital of Anhui Medical University(CN)Xijing Hospital(CN)Yunnan University of Traditional Chinese Medicine(CN)Air Force Medical University(CN)
Publications by Year
Research Areas
Cervical Cancer and HPV Research, Cancer Immunotherapy and Biomarkers, Lung Cancer Treatments and Mutations, Global Cancer Incidence and Screening, Hepatitis B Virus Studies
Most-Cited Works
- → Synergistic and low adverse effect cancer immunotherapy by immunogenic chemotherapy and locally expressed PD-L1 trap(2018)399 cited
- → Soluble PD-L1 as a Biomarker in Malignant Melanoma Treated with Checkpoint Blockade(2017)358 cited
- → Statins Induce the Accumulation of Regulatory T Cells in Atherosclerotic Plaque(2012)110 cited
- → One-step amine modification of graphene oxide to get a green trifunctional metal-free catalyst(2015)86 cited
- → A Model To Identify Individuals at High Risk for Esophageal Squamous Cell Carcinoma and Precancerous Lesions in Regions of High Prevalence in China(2017)74 cited
- → Global burden of female breast cancer: new estimates in 2022, temporal trend and future projections up to 2050 based on the latest release from GLOBOCAN(2025)67 cited